Open AccessDepression and Serotonin Reuptake Inhibitor Treatment as Risk Factors for Preterm Birth
Author(s) -
Kimberly A. Yonkers,
Errol R. Norwitz,
Megan V. Smith,
Charles J. Lockwood,
Nathan Gotman,
Edward Luchansky,
Haiqun Lin,
Kathleen Belanger
Publication year - 2012
Publication title -
epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.901
H-Index - 173
eISSN - 1531-5487
pISSN - 1044-3983
DOI - 10.1097/ede.0b013e31825838e9
Subject(s) - serotonin reuptake inhibitor , depression (economics) , medicine , serotonin , economics , macroeconomics , receptor
Major depressive disorder and the use of serotonin reuptake inhibitors (SRIs) in pregnancy have been associated with preterm birth. Studies that have attempted to separate effects of illness from treatment have been inconclusive. We sought to explore the separate effects of SRI use and major depressive episodes in pregnancy on risk of preterm birth.